BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 15, 2026
Home » Authors » John Fox

John Fox

Articles

ARTICLES

Novel target identified for treating lactic acidosis

Sep. 16, 2015
By John Fox
HONG KONG — A new Japanese and U.S. collaborative study showing that inhibition of the oxygen sensor prolyl hydroxylase domain-containing protein 2 (PHD2) in the liver enhanced uptake of lactate for glucose production and ameliorated lactic acidosis, suggests that PHD2 may be a viable new therapeutic target for patients with life-threatening lactic acidosis.
Read More

Novel target identified for treating lactic acidosis

Sep. 11, 2015
By John Fox
HONG KONG — A new Japanese and U.S. collaborative study showing that inhibition of the oxygen sensor prolyl hydroxylase domain-containing protein 2 (PHD2) in the liver enhanced uptake of lactate for glucose production and ameliorated lactic acidosis, suggests that PHD2 may be a viable new therapeutic target for patients with life-threatening lactic acidosis.
Read More

Phospholipid directs neuron organization in spinal cord

Sep. 2, 2015
By John Fox
HONG KONG — A Japanese study has demonstrated how a phospholipid released by the nervous system’s glial cells controls the positioning of sensory neurons within the spinal cord, giving rise to the possibility that a lipid-based signaling system could be a therapeutic target for spinal cord injuries.
Read More

Phospholipid directs neuron organization in spinal cord

Sep. 1, 2015
By John Fox
HONG KONG — A Japanese study has demonstrated how a phospholipid released by the nervous system's glial cells controls the positioning of sensory neurons within the spinal cord, giving rise to the possibility that a lipid-based signaling system could be a therapeutic target for spinal cord injuries.
Read More

Androgen receptor finding key to prostate cancer drug design

Aug. 26, 2015
By John Fox
HONG KONG — The findings of a new study of gene regulation by androgen receptor (AR) splice variants (AR-Vs) by U.S and Chinese scientists could provide a pivotal pathway for drug designers to target, in order to disrupt AR-V signaling as a novel strategy for the effective treatment of advanced prostate cancer.
Read More

Androgen receptor finding key to prostate cancer drug design

Aug. 26, 2015
By John Fox
HONG KONG — The findings of a new study of gene regulation by androgen receptor (AR) splice variants (AR-Vs) by U.S and Chinese scientists could provide a pivotal pathway for drug designers to target, in order to disrupt AR-V signaling as a novel strategy for the effective treatment of advanced prostate cancer.
Read More

GITR antibody-mediated cancer immunotherapies mechanism described

Aug. 19, 2015
By John Fox
HONG KONG — The discovery that a novel mechanism of CD4+ T helper (Th) cell differentiation is mediated by co-stimulation of glucocorticoid-induced tumor necrosis factor receptor- (TNFR)-related protein (GITR) explains the mechanism of action of GITR-mediated cancer immunotherapies and warrants clinical trials of GITR agonists, a Korean study has found.
Read More

GITR antibody-mediated cancer immunotherapies mechanism described

Aug. 18, 2015
By John Fox
HONG KONG — The discovery that a novel mechanism of CD4+ T helper (Th) cell differentiation is mediated by co-stimulation of glucocorticoid-induced tumor necrosis factor receptor- (TNFR)-related protein (GITR) explains the mechanism of action of GITR-mediated cancer immunotherapies and warrants clinical trials of GITR agonists, a Korean study has found.
Read More

Chemical reprogramming can transform skin cells into neurons

Aug. 12, 2015
By John Fox
HONG KONG – Two stem cell labs in China have independently reported the successful transformation of fibroblasts into functional neurons using only chemicals, with one group using human cells from healthy individuals and Alzheimer's patients, while the other used mouse cells, potentially providing other sources of neuronal cells for drug discovery and regenerative medicine.
Read More

Chemical reprogramming can transform skin cells into neurons

Aug. 11, 2015
By John Fox
HONG KONG – Two stem cell labs in China have independently reported the successful transformation of fibroblasts into functional neurons using only chemicals, with one group using human cells from healthy individuals and Alzheimer's patients, while the other used mouse cells, potentially providing other sources of neuronal cells for drug discovery and regenerative medicine.
Read More
View All Articles by John Fox

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 15, 2026.
  • Illustration of Lactobacillus

    Microbiota modulates the antidepressant effects of GLP-1 analogues

    BioWorld Science
    Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...
  • Neck exam

    Ethyreal launches to treat the underlying cause of Graves’, TED

    BioWorld
    Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
  • Genome sequence map

    EHA 2026: With new lenses, a changing view on pediatric cancers

    BioWorld
    In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
  • Microscopic image of chronic myeloid leukemia

    Enliven’s phase I CML data Enable phase III with BCR/ABL1 bid

    BioWorld
    Tolerability is a key factor in the appeal of Enliven Therapeutics Inc.’s ELVN-001 for previously treated chronic myeloid leukemia (CML), which yielded positive...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing